E3 PreliminaryPreliminaryPEM requiredMechanisticPeer-reviewedMachine draft
Detection of Urine Metabolites in a Rat Model of Chronic Fatigue Syndrome before and after Exercise.
Shao, Changzhuan, Ren, Yiming, Wang, Zinan et al. · BioMed research international · 2017 · DOI
Quick Summary
Researchers used rats exposed to stress and exercise to model ME/CFS and then measured chemicals in their urine before and after exercise. They found abnormalities in how the rats' bodies produce energy and process hormones, particularly in molecules called sphingosine and a hormone precursor called 21-hydroxypregnenolone. These findings suggest that ME/CFS may involve disrupted energy metabolism and problems with the body's stress-response system.
Why It Matters
This study provides preclinical mechanistic evidence that ME/CFS involves metabolic and hormonal abnormalities that persist and change with exercise, supporting the hypothesis that HPA axis dysfunction and altered lipid metabolism contribute to the illness. Identifying potential biomarkers like sphingosine could help develop diagnostic tools and targeted treatments for patients.
Observed Findings
- Twenty distinct urine metabolites were detected with significant alterations in CFS rats.
- Three metabolic pathways (TCA cycle, amino acid metabolism, steroid hormone biosynthesis) showed significant changes both before and after exercise.
- Sphingolipid metabolism exhibited significant alterations specifically after exercise in CFS rats.
- Sphinogosine and 21-hydroxypregnenolone were identified as potential key biomarkers associated with CFS-like disease.
Inferred Conclusions
- ME/CFS involves impairments in energy metabolism (TCA cycle) alongside disrupted steroid hormone biosynthesis, consistent with HPA axis hypoactivity.
- Sphingolipid metabolism may be particularly sensitive to exercise stress in ME/CFS.
- Urine metabolite profiles may serve as biomarkers for immune dysfunction and neuroendocrine abnormalities in ME/CFS.
Remaining Questions
- Do these same metabolic and hormonal abnormalities occur in human ME/CFS patients, and do they correlate with symptom severity or post-exertional malaise?
- Are the identified metabolite changes reversible with treatment, or are they stable markers of disease status?
- What is the mechanistic relationship between HPA axis hypoactivity and the observed changes in sphingolipid and steroid hormone metabolism?
What This Study Does Not Prove
This is a rat model study and cannot directly prove that these same metabolic changes occur in human ME/CFS patients. The study does not establish whether the observed metabolite changes are causes or consequences of the disease state, nor does it demonstrate clinical utility of these biomarkers in patient populations.
Tags
Symptom:Post-Exertional MalaiseFatigue
Biomarker:MetabolomicsBlood Biomarker
Method Flag:PEM Not DefinedWeak Case DefinitionExploratory Only
Metadata
- DOI
- 10.1155/2017/8182020
- PMID
- 28421200
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →